These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6367088)

  • 21. Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival.
    Chia D; Horimi T; Terasaki PI; Hermes M
    Transplant Proc; 1982 Jun; 14(2):322-4. PubMed ID: 7051474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The identification of lymphocyte phenotypes in peripheral blood of long-term renal allograft patients.
    Ziegelbaum M; Valenzuela R; Hayes JM; Graneto D; Steinmuller D; Streem SB; Novick AC
    Transplant Proc; 1989 Feb; 21(1 Pt 1):373-4. PubMed ID: 2650151
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of dialysis on renal transplantation.
    Tremann JA; Chrzanowski PJ; Tenckhoff HA; Moe RE; Quadracci LJ; Rosenzweig J; Striker GE; Marchioro TL
    Proc Clin Dial Transplant Forum; 1971; 1():6-10. PubMed ID: 4951043
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal allograft prognosis as a function of pretransplant parameters including transfusion history.
    Glass NR; Miller DT; Sollinger HW; Belzer FO
    Transplant Proc; 1982 Jun; 14(2):290-2. PubMed ID: 7051468
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies of lymphocyte-dependent antibody in human chronic renal allograft rejection.
    Thomas J; Thomas F; Lee HM
    Transplant Proc; 1977 Mar; 9(1):65-8. PubMed ID: 325798
    [No Abstract]   [Full Text] [Related]  

  • 26. Presensitization patterns in renal allograft recipients--a correlation with graft outcome.
    Moore SB; Taswell HF; Iwaki Y; Terasaki PI
    Ir J Med Sci; 1979; 148(9-10):267-71. PubMed ID: 397205
    [No Abstract]   [Full Text] [Related]  

  • 27. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L; Lee PC; Everly MJ; Terasaki PI
    Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged allograft survival of strong pretransplant immune responders treated with ATG.
    Kerman RH; Floyd M; Van Buren CT; Kahan BD
    Transplant Proc; 1981 Mar; 13(1 Pt 1):332-5. PubMed ID: 6455793
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravascular coagulation (IVC) in human renal allograft rejection.
    Busch GJ; Braun WE; Carpenter CB; Corson JM; Galvanek ER; Reynolds ES; Merrill JP; Dammin GJ
    Transplant Proc; 1969 Mar; 1(1):267-70. PubMed ID: 4944225
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of blood transfusion on immune responses and their relationship to renal allograft survival.
    Goeken NE; Flanigan MJ; Thompson JS; Corry RJ; Nghiem DD; Rhoades JL; Evans GA; Melton ZJ
    Transplant Proc; 1982 Jun; 14(2):338-40. PubMed ID: 6214062
    [No Abstract]   [Full Text] [Related]  

  • 31. Some remarks about the preceding paper by Prof. J.J. van Rood with regard to the interpretation of the results of kidney and skin allograft studies in man.
    Dausset J
    Transplant Proc; 1973 Dec; 5(4):1751-3. PubMed ID: 4590625
    [No Abstract]   [Full Text] [Related]  

  • 32. [Importance of examination for cytotoxic antibodies in the prospective kidney transplant recipient].
    Prochazkova E; Soucy PE; Daguillard F
    Union Med Can; 1974 Mar; 103(3):424-6. PubMed ID: 4595149
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibody and lymphocyte-mediated immunologic recipient versus donor reactions before and after human renal allotransplantation--a prospective study.
    Grunnet N; Kristensen T
    Transplant Proc; 1978 Sep; 10(3):531-3. PubMed ID: 362630
    [No Abstract]   [Full Text] [Related]  

  • 34. Predictive value of active T-RFC in renal allograft survival.
    Kerman RH; Ing TS; Hano JE; Geis WP
    Transplant Proc; 1978 Sep; 10(3):637-8. PubMed ID: 362650
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of antibodies to B lymphocytes in renal transplantation.
    Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart CH; Fine RN
    Transplant Proc; 1977 Mar; 9(1):751-3. PubMed ID: 325809
    [No Abstract]   [Full Text] [Related]  

  • 36. Variation in cytotoxic antibody response to transfusion in prospective renal allograft recipients.
    Perkins HA; Howell E; Gantan Z; Mims MC; Dickerson T; Senecal I
    Transplantation; 1974 Feb; 17(2):216-20. PubMed ID: 4590291
    [No Abstract]   [Full Text] [Related]  

  • 37. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC; Zhu L; Terasaki PI; Everly MJ
    Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithymocyte globulin-induced prolongation of human renal allograft survival in recipients with in vitro steroid-resistant ADCC.
    Dumble LJ; Clunie GJ; Macdonald IM; Bowes LG; Kincaid-Smith P
    Transplant Proc; 1984 Dec; 16(6):1503-5. PubMed ID: 6390854
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute and hyperacute humoral rejection in kidney allograft recipients treated with anti-human thymocyte antibodies.
    Colovai AI; Vasilescu ER; Foca-Rodi A; Kim-Schulze S; Hussaini N; D'agati VD; Markowitz GS; Wang C; Cohen DJ; Hardy MA; Suciu-Foca N
    Hum Immunol; 2005 May; 66(5):501-12. PubMed ID: 15935887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.